Anti-Connective Tissue Growth Factor Antibody Treatment Reduces Extracellular Matrix Production in Trabecular Meshwork and Lamina Cribrosa Cells
Investigative Ophthalmology & Visual Science2013Vol. 54(13), pp. 7836–7836
Citations Over TimeTop 10% of 2013 papers
Abstract
FG-3019 is effective in blocking extracellular matrix production in TM and LC cells, thus supporting a role for the use of anti-CTGF immunotherapy in the treatment of glaucoma.
Related Papers
- → Role of Fibronectin in Primary Open Angle Glaucoma(2019)74 cited
- → Functional properties of fibronectin in the trabecular meshwork(2008)76 cited
- The Effect of Haikunshenxi Caps on the Connective Tissue Growth Factor Protein and its mRNA’s Expression on Adriamycin-induced Nephropathicy Rats(2006)
- Expression of connective tissue growth factor in keratinocytes of oral submucous fibrosis(2006)
- → Effect of fibronectin on proliferation, adhesion and migration in cultured primary open-angle glaucoma trabecular meshwork cells(2010)